Published in Medical Letter on the CDC and FDA, July 1st, 2007
The report was issued by FDA's Human Tissue Task Force (HTTF), an intra-agency group assembled in August 2006 to evaluate the effectiveness of FDA's tissue regulations.
The HTTF recommended targeted inspections or a "blitz" of U.S. companies that recover human tissues - including tendons, ligaments, bone and other musculoskeletal tissues. One goal of the blitz was to look for more widespread problems in tissue recovery after FDA ordered two companies to cease...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.